Supply Chain

Four health systems from across the country plan to form a nonprofit generic drug company to address the high costs and shortages of generic medications.

Population health management is a key initiative for hospitals to improve care quality, lower costs and increase efficiencies to succeed in risk-based contracting, according to Mike Long, president of Pharmacy Healthcare Solutions at AmerisourceBergen.

AuroMedics Pharma recalled one lot of levofloxacin in 5 percent dextrose injection due to possible mold contamination.

Johnson & Johnson is looking to divest its diabetes care business to Chinese buyers in a deal that could be worth up to $4 billion, unnamed sources told Reuters.

Here are six articles Becker's Hospital Review published in the last week, highlighting a recent surge in demand for anti-radiation pills and a potential shortage of IV containers, among other topics.

Dr. Reddy's Laboratories on Jan. 9 recalled 1,051 vials of the cancer drug Docetaxel, according to the FDA's enforcement report for the week of Jan. 17.

Baxter on Jan. 16 expanded a voluntary recall of its drug Nexterone, which is used to treat heart arrhythmias.

The FDA expects the national saline bag shortage to improve in the coming weeks and months, but warns of a potential IV container shortage, according to Reuters.

Hospitals are strained for resources, space and staff members amid the 2017-18 flu season, highlighting the U.S. healthcare system's lack of preparedness for a mass pandemic or other medical emergencies, according to NBC News.

The FDA and Department of Defense's Office of Health Affairs on Tuesday unveiled a joint program to expedite the development and regulatory review of medical products for American military personnel.